Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

W. Lam, A. Nowak, F. Chen, S. Muruganandan, S. Arunachalam, M. Chin, M. Millward, C. Read, K. Murray, J. Creaney, Y. C. G. Lee

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)S342-S342
Number of pages1
JournalJournal of Thoracic Oncology
Issue number10
Publication statusPublished - Oct 2019

Cite this